Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00203255 · ClinicalTrials.gov registry record · NA
Clinical Study Examining Use of an Over-the-Counter Supplement for the Prevention of Menstrually-Associated Migraine Headache
A NA study of Migraine Headache, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT00203255: Completed NA study of Migraine Headache, sponsored by Thomas Jefferson University.
NCT00203255 is a NA study of Migraine Headache that has completed, run by Thomas Jefferson University. The registered enrollment target is 25 participants, below the 155-participant average among 6 other Migraine Headache trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00203255, a NA study of Migraine Headache, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this trial is to study the use of soy isoflavones in the prevention of menstrually-associated migraines. Additionally, this trial may provide insight into the menstrual cycle and menstrually-related headaches in women. With this information, we may be able to change current treatment methods or even develop new methods in order to advance current approaches in the treatment of menstrual migraine.
Conditions Studied
Interventions
- DRUG Soy Isoflavones
Study Locations (1)
Pennsylvania
- Jefferson Headache Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2003-05 |
| Est. Completion | 2005-03 |
| Phase | NA |
What the finished NCT00203255 record still lists
NCT00203255 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 155-participant average among 6 other Migraine Headache trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Migraine Headache appearing as the primary indexed condition, and to 1 intervention - of which Soy Isoflavones is the first listed.
NCT00203255 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00203255 about?
NCT00203255 is a clinical study titled "Clinical Study Examining Use of an Over-the-Counter Supplement for the Prevention of Menstrually-Associated Migraine Headache". The purpose of this trial is to study the use of soy isoflavones in the prevention of menstrually-associated migraines. Additionally, this trial may provide insight into the menstrual cycle and menstrually-related headaches in women. With this information, we may be able to change current treatment ...
What is the current status of trial NCT00203255?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2003-05. Estimated completion is 2005-03.
What conditions does trial NCT00203255 study?
This clinical trial studies the following conditions: Migraine Headache.
What interventions are being tested in trial NCT00203255?
The interventions under investigation include: Soy Isoflavones (DRUG).
Who is sponsoring clinical trial NCT00203255?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00203255 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine Headache
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Light Exposure, Migraine Outcomes, and Sleep Quality
RECRUITING · NA
-
TelemEdiciNe-bAsed Cognitive TherapY for Migraines
COMPLETED · NA
-
Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine
COMPLETED · NA
-
Efficacy, Tolerability, and Safety of DFN-15
COMPLETED · Phase 3
-
Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache
COMPLETED · Phase 2
-
Greater Occipital Nerve Block for Migraine Prophylaxis
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia